Clinical Trials Logo

Clinical Trial Details — Status: No longer available

Administrative data

NCT number NCT02142868
Other study ID # A5481034
Secondary ID
Status No longer available
Phase
First received
Last updated

Study information

Verified date December 2018
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority
Study type Expanded Access

Clinical Trial Summary

To provide access to palbociclib to post-menopausal women with HR-positive, HER2-negative advanced breast cancer who are deemed appropriate for letrozole therapy (Canada: first-line patients only).


Description:

This study is currently available in Canada only.


Recruitment information / eligibility

Status No longer available
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Post-menopausal women 18 years of age or above with proven diagnosis of advanced adenocarcinoma of the breast (locoregionally recurrent or metastatic disease)

- ER-positive and/or PR-positive tumor based on local laboratory results

- HER2-negative tumor based on local laboratory results

- Patients must be appropriate candidates for letrozole therapy (Canada: first-line patients only)

Exclusion Criteria:

- Patients who have previously participated in a palbociclib trial or who have received prior treatment with any CDK inhibitor

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Palbociclib
Palbociclib will be administered orally once a day at 125 mg/day for 21 days followed by 7 days off treatment for each 28-day cycle (Schedule 3/1)
Letrozole
Letrozole will be administered orally at 2.5 mg once daily as continuous daily dosing schedule according to product labeling and in compliance with its local prescribing information.

Locations

Country Name City State
Canada Holy Cross Centre Calgary Alberta
Canada Tom Baker Cancer Centre Calgary Alberta
Canada Cross Cancer Institute Edmonton Alberta
Canada Queen Elizabeth II (QEII) Health Sciences Centre, Nova Scotia Cancer Centre Halifax Nova Scotia
Canada London Regional Cancer Program London Ontario
Canada McGill University Health Centre (MUHC), Glen Site, Royal Victoria Hospital, Cedars Cancer Centre Montreal Quebec
Canada The Ottawa Hospital Cancer Centre Ottawa Ontario
Canada CHU de Quebec - Hospital du Saint-Sacrement Quebec
Canada Sunnybrook health Sciences Centre Toronto Ontario
Canada Sunnybrook Odette Cancer Centre Toronto Ontario
Canada SunnyBrook Research Institute Toronto Ontario
United States CBCC Global Research, Inc. at Comprehensive Blood & Cancer Center Research Center Bakersfield California
United States SKCCC at Johns Hopkins, The Harry and Jeannette Weinberg Building Baltimore Maryland
United States UPMC Cancer Center Beaver Beaver Pennsylvania
United States Presence Saint Joseph Hospital Chicago Illinois
United States The West Clinic, P.C. Corinth Mississippi
United States North Shore Oncology-Hematology Associates, Ltd. Crystal Lake Illinois
United States Texas Oncology -Baylor Charles A. Sammons Cancer Center Dallas Texas
United States Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care Duluth Georgia
United States Medical Oncology & Hematology Associates of Northern Virginia, Ltd. Fairfax Virginia
United States The West Clinic, P.C. d/b/a West Cancer Center Germantown Tennessee
United States UPMC Cancer Center Arnold Palmer at Mountainview Greensburg Pennsylvania
United States UPMC Cancer Center Greenville Greenville Pennsylvania
United States Texas Oncology - Memorial City Houston Texas
United States Jackson Oncology Associates, PLLC Jackson Mississippi
United States Jackson Oncology Associates, PLLC Jackson Mississippi
United States Mississippi Baptist Health Systems Jackson Mississippi
United States ProHealthCARE Associates, LLP Lake Success New York
United States Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care Lawrenceville Georgia
United States North Shore Oncology-Hematology Associates, Ltd. Libertyville Illinois
United States SKCCC at Johns Hopkins, Green Spring Station Lutherville Maryland
United States The West Clinic, P.C. d/b/a West Cancer Center Memphis Tennessee
United States The West Clinic, P.C. d/b/a West Cancer Center Memphis Tennessee
United States Metairie Oncologist, LLC Metairie Louisiana
United States UPMC Cancer Center Monroeville Monroeville Pennsylvania
United States Presence Medical Group Hematology Oncology Northbrook Illinois
United States Illinois CancerCare, P.C. Peoria Illinois
United States Magee-Womens Hospital of UPMC Pittsburgh Pennsylvania
United States University of Pittsburgh Cancer Institute, Investigational Drug Service, William M. Cooper Pavilion Pittsburgh Pennsylvania
United States University of Pittsburgh Medical Center, William M. Cooper Pavilion, Hillman Cancer Center Pittsburgh Pennsylvania
United States UPMC Cancer Center Passavant (HOA) Pittsburgh Pennsylvania
United States UPMC Cancer Center Passavant (OHA) Pittsburgh Pennsylvania
United States UPMC Cancer Center St. Margarets Pittsburgh Pennsylvania
United States Northwest Cancer Specialists dba Compass Oncology Portland Oregon
United States Northwest Cancer Specialists dba Compass Oncology Portland Oregon
United States Medical Oncology & Hematology Associates of Northern Virginia, Ltd. Reston Virginia
United States Swedish Cancer Institute Seattle Washington
United States UPMC Cancer Center Northwest Seneca Pennsylvania
United States Presence Infusion Care - Skokie Skokie Illinois
United States The West Clinic, P.C. d/b/a West Cancer Center Southaven Mississippi
United States Mount Nittany Medical Center State College Pennsylvania
United States Northwest Cancer Specialists dba Compass Oncology Vancouver Washington
United States Northwest Cancer Specialists dba Compass Oncology Vancouver Washington
United States MedStar Georgetown University Hospital Washington District of Columbia
United States Washington Cancer Institute at MedStar Washington Hospital Center Washington District of Columbia

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Countries where clinical trial is conducted

United States,  Canada,